Stephen C. Fehr
Stephen C. Fehr
Stephen Fehr is a senior officer with Pew's state and local fiscal health initiative, which researches state budget issues and provides policy guidance to help policymakers manage finances through the turns in the economy.
As a lead researcher on the project, Fehr oversees a wide-ranging portfolio that includes state intervention efforts in distressed local governments, state revenue systems, rainy day funds, borrowing, public pensions, and state tax policy. He is a frequent speaker to professional and academic associations and contributes to Stateline, the daily news service of The Pew Charitable Trusts.
Fehr, who joined Pew in 2008, draws from 33 years’ experience as a reporter and editor at the Washington Post and the Kansas City Star. During those years, he covered every level of government, from city councils and school boards to state legislatures, governors, Congress, and the White House.
Fehr holds a bachelor of journalism degree from the University of Missouri-Columbia.
Recent WorkView All
A bill up for a vote in the U.S. House of Representatives—H.R. 1335 to reauthorize the Magnuson-Stevens Fishery Conservation and Management Act, the primary law governing U.S. ocean fish—would significantly undercut the nation’s progress in preventing overfishing and rebuilding depleted fish populations. Read More
The Pew Charitable Trusts today commended Wal-Mart for announcing that it will ask all its suppliers of meat, poultry, seafood, dairy, and eggs to adopt and implement the American Veterinary Medical Association’s principles on the judicious use of antibiotics. The suppliers will provide Wal-Mart and the public with regular updates of antibiotic use in their food production. Read More
The Pew Charitable Trusts sent a letter to the leadership of the House Energy and Commerce Committee, Representatives Fred Upton (R-MI) and Frank Pallone (D-NJ), strongly supporting Section 2121 of the 21st Century Cures Act. This section would establish a much-needed approval pathway to speed patient access to new antibacterial drugs that treat serious or life-threatening infections where an... Read More